Troponin I biomarker as a strong prognostic factor for predicting COVID-19 mortality: A systematic review

Table 3 The baseline details of studies included in our meta-analysis considering the survived and non-survived groups

Ref.	Country	Population	Mean age	Male/female	Mean TnI
Aladağ and Atabey[27]	Turkey	Survived: 35	68 ± 14	22/13	Survived: 0.001 ng/mL
		Non-survived: 15	68 ± 15	6/9	Non-survived: 0.010 ng/mL
Deng et al[28]	China	Survived: 212	62 ± 11	97/115	Survived: 0.006 ng/mL
		Non-survived: 52	74 ± 15	33/19	Non-survived: 0.051 ng/mL
Liberati et al[15]	Italy	Survived: 425	61 ± 13	287/138	Survived: 0.006 ng/mL
		Non-survived: 98	76 ± 10	68/30	Non-survived: 0.036 ng/mL
Nie et al[29]	China	Survived: 200	60 ± 11	180/20	Survived: 0.002 ng/mL
		Non-survived: 111	72 ± 12	88/23	Non-survived: 0.032 ng/mL
Rath et al[30]	Germany	Survived: 107	67 ± 15	65/42	Survived: 0.014 ng/mL
		Non-survived: 16	73 ± 16	12/4	Non-survived: 0.024 ng/mL
Shi et al[31]	China	Survived: 609	61 ± 13	287/322	Survived: 0.006 ng/mL
		Non-survived: 62	74 ± 15	35/27	Non-survived: 0.023 ng/mL
Yang et al[32]	China	Survived: 145	57 ± 13	77/68	Survived: 0.004 ng/mL
		Non-survived: 58	67 ± 15	38/20	Non-survived: 0.020 ng/mL